Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;44(2):172-200.
doi: 10.1111/jvp.12917. Epub 2020 Oct 21.

The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal

Pierre-Louis Toutain  1   2 , Ludovic Pelligand  2 , Peter Lees  2 , Alain Bousquet-Mélou  1 , Aude A Ferran  1 , John D Turnidge  3
Affiliations
Review

The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal

Pierre-Louis Toutain et al. J Vet Pharmacol Ther. 2021 Mar.

Abstract

Pharmacokinetic/pharmacodynamic (PK/PD) modelling is the initial step in the semi-mechanistic approach for optimizing dosage regimens for systemically acting antimicrobial drugs (AMDs). Numerical values of PK/PD indices are used to predict dose and dosing interval on a rational basis followed by confirmation in clinical trials. The value of PK/PD indices lies in their universal applicability amongst animal species. Two PK/PD indices are routinely used in veterinary medicine, the ratio of the area under the curve of the free drug plasma concentration to the minimum inhibitory concentration (MIC) (fAUC/MIC) and the time that free plasma concentration exceeds the MIC over the dosing interval (fT > MIC). The basic concepts of PK/PD modelling of AMDs were established some 20 years ago. Earlier studies have been reviewed previously and are not reconsidered in this review. This review describes and provides a critical appraisal of more recent, advanced PK/PD approaches, with particular reference to their application in veterinary medicine. Also discussed are some hypotheses and new areas for future developments.First, a brief overview of PK/PD principles is presented as the basis for then reviewing more advanced mechanistic considerations on the precise nature of selected indices. Then, several new approaches to selecting PK/PD indices and establishing their numerical values are reviewed, including (a) the modelling of time-kill curves and (b) the use of population PK investigations. PK/PD indices can be used for dose determination, and they are required to establish clinical breakpoints for antimicrobial susceptibility testing. A particular consideration is given to the precise nature of MIC, because it is pivotal in establishing PK/PD indices, explaining that it is not a "pharmacodynamic parameter" in the usual sense of this term.

Keywords: PK/PD; antimicrobials; dosage regimen; veterinary medicine.

PubMed Disclaimer

References

REFERENCES

    1. Ahmad, I., Huang, L., Hao, H., Sanders, P., & Yuan, Z. (2016). Application of PK/PD modeling in veterinary field: dose optimization and drug resistance prediction. BioMed Research International, 2016, 1-12. https://doi.org/10.1155/2016/5465678
    1. Aliabadi, F. S., Landoni, M. F., & Lees, P. (2003). Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy, 47(2), 626-635. https://doi.org/10.1128/AAC.47.2.626-635.2003
    1. Aliabadi, F. S., & Lees, P. (2001). Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research, 62(12), 1979-1989. https://doi.org/10.2460/ajvr.2001.62.1979
    1. Aliabadi, F. S., & Lees, P. (2002). Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate. Journal of Veterinary Pharmacology and Therapeutics, 25(3), 161-174. https://doi.org/10.1046/j.1365-2885.2002.00399.x
    1. Ambrose, P. G. (2017). Antibacterial drug development program successes and failures: A pharmacometric explanation. Current Opinion in Pharmacology, 36, 1-7. https://doi.org/10.1016/j.coph.2017.06.002

MeSH terms

Substances

LinkOut - more resources